Methodology for adaptation of the ASH Guidelines for Management of Venous Thromboembolism for the Latin American context
Tóm tắt
Tài liệu tham khảo
Alonso-Coello, 2016, GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction, BMJ., 353, i2016, 10.1136/bmj.i2016
Qaseem, 2012, Guidelines International Network: toward international standards for clinical practice guidelines, Ann Intern Med., 156, 525, 10.7326/0003-4819-156-7-201204030-00009
Izcovich, 2020, A user guide to the American Society of Hematology clinical practice guidelines, Blood Adv., 4, 2095, 10.1182/bloodadvances.2020001755
Sun, 2012, Credibility of claims of subgroup effects in randomised controlled trials: systematic review, BMJ., 344, e1553, 10.1136/bmj.e1553
Wiercioch, 2020, Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences, Blood Adv., 4, 2351, 10.1182/bloodadvances.2020001768
Schünemann, 2017, GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT, J Clin Epidemiol., 81, 101, 10.1016/j.jclinepi.2016.09.009
Ortel, 2020, American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism, Blood Adv., 4, 4693, 10.1182/bloodadvances.2020001830
Witt, 2018, American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy, Blood Adv., 2, 3257, 10.1182/bloodadvances.2018024893
Anderson, 2019, American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients, Blood Adv., 3, 3898, 10.1182/bloodadvances.2019000975
Schünemann, 2018, American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients, Blood Adv., 2, 3198, 10.1182/bloodadvances.2018022954